4//SEC Filing
Casey Mark J 4
Accession 0001209191-23-058519
CIK 0001000694other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 5:00 PM ET
Size
8.3 KB
Accession
0001209191-23-058519
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Casey Mark J
EVP, Chief Legal Officer
Transactions
- Award
Restricted Stock Units
2023-12-11+125,698→ 125,698 total→ Common Stock (125,698 underlying) - Award
Stock Options (Right to buy)
2023-12-11+144,694→ 144,694 totalExercise: $5.57From: 2024-12-11Exp: 2033-12-11→ Common Stock (144,694 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the December 11, 2023 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
- [F3]The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001415297
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 5:00 PM ET
- Size
- 8.3 KB